Skip to main content
×
Home
    • Aa
    • Aa

Seroprevalence of Bordetella pertussis in the Mexican population: a cross-sectional study

  • C. CONDE-GLEZ (a1), E. LAZCANO-PONCE (a1), R. ROJAS (a1), R. DeANTONIO (a2), L. ROMANO-MAZZOTTI (a3), Y. CERVANTES (a3) and E. ORTEGA-BARRÍA (a4)...
Abstract
SUMMARY

Serum samples collected during the National Health and Nutrition survey (ENSANUT 2006) were obtained from subjects aged 1–95 years (January–October 2010) and analysed to assess the seroprevalence of Bordetella pertussis (BP) in Mexico. Subjects' gender, age, geographical region and socioeconomic status were extracted from the survey and compiled into a subset database. A total of 3344 subjects (median age 29 years, range 1–95 years) were included in the analysis. Overall, BP seroprevalence was 47·4%. BP seroprevalence was significantly higher in males (53·4%, P = 0·0007) and highest in children (59·3%) decreasing with advancing age (P = 0·0008). BP seroprevalence was not significantly different between regions (P = 0·1918) and between subjects of socioeconomic status (P = 0·0808). Women, adolescents and young adults were identified as potential sources of infection to infants. Booster vaccination for adolescents and primary contacts (including mothers) for newborns and infants may provide an important public health intervention to reduce the disease burden.

Copyright
Corresponding author
*Author for correspondence: Dr C. Conde-Glez, Instituto Nacional de Salud Pública, Avenida Universidad655, Colonia Santa María Ahuacatitlán, 62508 Cuernavaca, Morelos, México. (Email: cjconde@insp.mx)
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1. N Guiso , J Liese , S Plotkin . The Global Pertussis Initiative: meeting report from the fourth regional roundtable meeting, France, April 14–15, 2010. Human Vaccines 2011; 7: 481488.

4. RE Black , Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 2010; 375: 19691987.

8. R Ulloa-Gutierrez , The Global Pertussis Initiative: meeting report from the regional Latin America meeting, Costa Rica, 5–6 December, 2008. Human Vaccines 2010; 6: 876880.

10. N Guiso , The Global Pertussis Initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11–12 January 2010. Vaccine 2011; 29: 11151121.

11. P Rendi-Wagner , The seroepidemiology of Bordetella pertussis in Israel – estimate of incidence of infection. Vaccine 2010; 28: 32853290.

12. U Heininger , JD Cherry . Pertussis immunization in adolescents and adults – Bordetella pertussis epidemiology should guide vaccination recommendations. Expert Opinion on Biological Therapy 2006; 6: 685697.

15. M Riffelmann , Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis. Journal of Clinical Microbiology 2010; 48: 44594463.

20. BA Halperin , Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women. Clinical Infectious Diseases 2011; 53: 885892.

21. B Esen , Prevalence of high antibody titers of pertussis in Turkey: reflection of circulating microorganism and a threat to infants. Journal of Clinical Laboratory Analysis 2007; 21: 154161.

23. M Libster , KM Edwards . Re-emergence of pertussis: what are the solutions? Expert Review of Vaccines 2012; 11: 13311346.

27. HE De Melker , The incidence of Bordetella pertussis infection estimated in the population from a combination of serological surveys. Journal of Infection 2006; 53: 106113.

28. P Olin , Randomized controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the study of pertussis vaccines. Lancet 1997; 350: 15691577.

29. SC De Greef , Seroprevalence of pertussis in the Netherlands: evidence for increased circulation of Bordetella pertussis. PLoS ONE 2010; 5: e14183.

31. DA Brooks , R Clover . Pertussis infection in the United States: role for vaccination of adolescents and adults. Journal of the American Board of Family Medicine 2006; 19: 603611.

34. JL Valdespino , Seroepidemiology of hepatitis A in Mexico. A detector of social inequity and monitor of immunization policies. Salud Publica de Mexico 2007; 49 (Suppl. 3): S377S385.

35. CM Healy , MA Rench , CJ Baker . Implementation of cocooning against pertussis in a high-risk population. Clinical Infectious Diseases 2011; 52: 157162.

37. DM Skowronski , The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunization. Clinical Infectious Diseases 2012; 54: 318327.

38. F Munoz , J Englund . Infant pertussis: Is cocooning the answer? Clinical Infectious Diseases 2011; 53: 893896.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 3
Total number of PDF views: 19 *
Loading metrics...

Abstract views

Total abstract views: 133 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 27th March 2017. This data will be updated every 24 hours.